Human Relaxin‐2 Fusion Protein Treatment Prevents and Reverses Isoproterenol‐Induced Hypertrophy and Fibrosis in Mouse Heart

BACKGROUND: Heart failure is one of the leading causes of death in Western countries, and there is a need for new therapeutic approaches. Relaxin‐2 is a peptide hormone that mediates pleiotropic cardiovascular effects, including antifibrotic, angiogenic, vasodilatory, antiapoptotic, and anti‐inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Junhui, Hao, Weidong, Fillmore, Natasha, Ma, Hanley, Springer, Danielle, Yu, Zu‐Xi, Sadowska, Agnieszka, Garcia, Andrew, Chen, Ruoyan, Muniz‐Medina, Vanessa, Rosenthal, Kim, Lin, Jia, Kuruvilla, Denison, Osbourn, Jane, Karathanasis, Sotirios K., Walker, Jill, Murphy, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951077/
https://www.ncbi.nlm.nih.gov/pubmed/31818212
http://dx.doi.org/10.1161/JAHA.119.013465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951077/
https://www.ncbi.nlm.nih.gov/pubmed/31818212
http://dx.doi.org/10.1161/JAHA.119.013465

Ejemplares similares